Analysis | Metabolite Name | Measured Value | Units | Gender | Glycemic status | Neuropathy |
---|---|---|---|---|---|---|
Reversed phase NEGATIVE ION MODE | ARACHIDONIC ACID (M-H)- | 280788 | Peak area normalized | male | Diabetic | no neuropathy |
Reversed phase NEGATIVE ION MODE | ARACHIDONIC ACID (M-H)- | 304637 | Peak area normalized | male | Pre-diabetic | no neuropathy |
Reversed phase NEGATIVE ION MODE | ARACHIDONIC ACID (M-H)- | 328328 | Peak area normalized | female | Diabetic | Neuropathy |
Reversed phase NEGATIVE ION MODE | ARACHIDONIC ACID (M-H)- | 331690 | Peak area normalized | female | Diabetic | no neuropathy |
Reversed phase NEGATIVE ION MODE | ARACHIDONIC ACID (M-H)- | 353446 | Peak area normalized | female | Pre-diabetic | no neuropathy |
Reversed phase NEGATIVE ION MODE | ARACHIDONIC ACID (M-H)- | 371145 | Peak area normalized | male | Normoglycemic | Neuropathy |
Reversed phase NEGATIVE ION MODE | ARACHIDONIC ACID (M-H)- | 372516 | Peak area normalized | male | Diabetic | no neuropathy |
Reversed phase NEGATIVE ION MODE | ARACHIDONIC ACID (M-H)- | 373974 | Peak area normalized | male | Pre-diabetic | no neuropathy |
Reversed phase NEGATIVE ION MODE | ARACHIDONIC ACID (M-H)- | 376550 | Peak area normalized | female | Pre-diabetic | Neuropathy |
Reversed phase NEGATIVE ION MODE | ARACHIDONIC ACID (M-H)- | 384118 | Peak area normalized | male | Normoglycemic | no neuropathy |
Reversed phase NEGATIVE ION MODE | ARACHIDONIC ACID (M-H)- | 384508 | Peak area normalized | female | Pre-diabetic | no neuropathy |
Reversed phase NEGATIVE ION MODE | ARACHIDONIC ACID (M-H)- | 405322 | Peak area normalized | male | Diabetic | Neuropathy |
Reversed phase NEGATIVE ION MODE | ARACHIDONIC ACID (M-H)- | 411995 | Peak area normalized | female | Pre-diabetic | Neuropathy |
Reversed phase NEGATIVE ION MODE | ARACHIDONIC ACID (M-H)- | 429627 | Peak area normalized | female | Pre-diabetic | Neuropathy |
Reversed phase NEGATIVE ION MODE | ARACHIDONIC ACID (M-H)- | 454170 | Peak area normalized | female | Pre-diabetic | Neuropathy |
Reversed phase NEGATIVE ION MODE | ARACHIDONIC ACID (M-H)- | 456431 | Peak area normalized | male | Diabetic | Neuropathy |
Reversed phase NEGATIVE ION MODE | ARACHIDONIC ACID (M-H)- | 469020 | Peak area normalized | female | Diabetic | Neuropathy |
Reversed phase NEGATIVE ION MODE | ARACHIDONIC ACID (M-H)- | 486541 | Peak area normalized | female | Pre-diabetic | no neuropathy |
Reversed phase NEGATIVE ION MODE | ARACHIDONIC ACID (M-H)- | 491473 | Peak area normalized | female | Diabetic | no neuropathy |
Reversed phase NEGATIVE ION MODE | ARACHIDONIC ACID (M-H)- | 496122 | Peak area normalized | male | Pre-diabetic | Neuropathy |
Reversed phase NEGATIVE ION MODE | ARACHIDONIC ACID (M-H)- | 502862 | Peak area normalized | male | Pre-diabetic | Neuropathy |
Reversed phase NEGATIVE ION MODE | ARACHIDONIC ACID (M-H)- | 503164 | Peak area normalized | male | Normoglycemic | Neuropathy |
Reversed phase NEGATIVE ION MODE | ARACHIDONIC ACID (M-H)- | 531882 | Peak area normalized | female | Pre-diabetic | no neuropathy |
Reversed phase NEGATIVE ION MODE | ARACHIDONIC ACID (M-H)- | 538191 | Peak area normalized | male | Diabetic | Neuropathy |
Reversed phase NEGATIVE ION MODE | ARACHIDONIC ACID (M-H)- | 564441 | Peak area normalized | male | Normoglycemic | no neuropathy |
Reversed phase NEGATIVE ION MODE | ARACHIDONIC ACID (M-H)- | 637112 | Peak area normalized | male | Diabetic | no neuropathy |